Thyroid function and weight loss after Roux-en-Y gastric bypass: observational study

Author(s):  
de Carvalho Gisah Amaral ◽  
Cleo Mesa ◽  
Rodrigo Strobel ◽  
Paula Carolina Dambros Granzotto
2020 ◽  
Vol 16 (2) ◽  
pp. 261-269
Author(s):  
Paula Carolina Dambros Granzotto ◽  
Cleo Otaviano Mesa Junior ◽  
Rodrigo Strobel ◽  
Rosana Radominski ◽  
Hans Graf ◽  
...  

2008 ◽  
Vol 41 (1) ◽  
pp. 30-31
Author(s):  
FRAN LOWRY
Keyword(s):  

Author(s):  
Fernando Munoz-Flores ◽  
Jorge Humberto Rodriguez-Quintero ◽  
David Pechman ◽  
Collin Creange ◽  
Ariela Zenilman ◽  
...  

2021 ◽  
Author(s):  
Nienke Slagter ◽  
Jonne Hopman ◽  
Anna G. Altenburg ◽  
Loek J. M. de Heide ◽  
Ewoud H. Jutte ◽  
...  

2021 ◽  
Vol 9 (1) ◽  
pp. e002033
Author(s):  
Erik Stenberg ◽  
Torsten Olbers ◽  
Yang Cao ◽  
Magnus Sundbom ◽  
Anders Jans ◽  
...  

IntroductionBariatric and metabolic surgery is an effective treatment option for type 2 diabetes (T2D). Increased knowledge regarding factors associated with diabetes remission is essential in individual decision making and could guide postoperative care. Therefore, we aimed to explore factors known to affect the chance of achieving diabetes remission after bariatric and metabolic surgery and to further investigate the impact of socioeconomic factors.Research design and methodsIn this nationwide study, we assessed all patients with T2D who underwent Roux-en-Y gastric bypass (RYGB) surgery between 2007 and 2015 in the Scandinavian Obesity Surgery Registry. Remission was defined as absence of antidiabetic medication for T2D 2 years after surgery. Multivariable logistic regression was used to evaluate factors associated with diabetes remission, with missing data handled by multiple imputations.ResultsA total of 8057 patients were included. Mean age±SD was 47.4±10.1 years, mean body mass index 42.2±5.7 kg/m2, mean hemoglobin A1c 59.0±17.33, and 61.7% (n=4970) were women. Two years after surgery, 6211 (77.1%) patients achieved T2D remission. Preoperative insulin treatment (OR 0.26, 95% CI 0.22 to 0.30), first-generation immigrant (OR 0.66, 95% CI 0.57 to 0.77), duration of T2D (OR 0.89, 95% CI 0.88 to 0.90), dyslipidemia (OR 0.71, 95% CI 0.62 to 0.81), age (OR 0.97, 95% CI 0.96 to 0.97), and high glycosylated hemoglobin A1c (HbA1c) (OR 0.99, 95% CI 0.98 to 0.99) were all associated with lower T2D remission rate. In contrast, residence in a medium-sized (OR 1.39, 95% CI 1.20 to 1.61) or small (OR 1.46, 95% CI 1.25 to 1.71) town and percentage of total weight loss (OR 1.04, 95% CI 1.03 to 1.04) were associated with higher remission rates.ConclusionAmong patients with T2D undergoing RYGB surgery, increasing age, HbA1c, and diabetes duration decreased the chance of reaching diabetes remission without cut-offs, while postoperative weight loss demonstrated a positive linear association. In addition, being a first-generation immigrant and living in a large city were socioeconomic factors having a negative association.


Sign in / Sign up

Export Citation Format

Share Document